MEDICINE SUPPLY CHAIN
The logistics behind the cell and gene therapies (CGT) supply chain is complex. That’s because autologous or allogeneic cell therapies typically have very tight and sometimes extreme time and temperature profiles. Not only that, it often involves making sure the right drug gets to the right patient – exactly at the right time.
With more than 40 years of life science and healthcare logistics experience, QuickSTAT has been helping the industry’s leading pharma and biotech companies bring new personalized medicines to market from the beginning. Our end-to-end solutions include temperature-controlled solutions, strict chain of custody and chain of identity for CGT distribution and expertise moving valuable cell banks. Plus, having designed and implemented the clinical supply chains for the first FDA-approved cancer vaccine and the first two FDA-approved CAR-T therapies, we are uniquely qualified to help with both clinical supply chain and commercial supply chain planning and execution for CGT.
From controlled room temperature to cryofrozen, our expertise in temperature-controlled logistics solutions includes global provisioning of active and passive packaging systems, in-transit storage, advanced monitoring systems and more.explore
CHAIN OF CUSTODY/ IDENTITY
Strict chain of custody and identity procedures include individual tracking of unique IDs and custom data, quality assurance protocols, temperature monitoring, geolocation tracking and more to ensure the security and integrity of your shipments.explore
Our range of advanced online and mobile tools and specialized software solutions are designed to help you manage your clinical supply chain logistics – delivering complete control and real-time visibility into critical shipments from beginning to end.explore